Patient-Reported Outcomes for Scalp, Eyebrow, and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from Two Phase 3 Clinical Trials

    September 2024 in “ Journal of the American Academy of Dermatology ”
    Lucy Liu, Arash Mostaghimi, Manabu Ohyama … Rodney Sinclair
    Studysummary In this study, patients with severe alopecia areata treated with baricitinib over 152 weeks experienced sustained patient-reported improvements in scalp, eyebrow, and eyelash hair regrowth, with higher responders observed in the 4mg dose group compared to the 2mg group.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Related research 8

    1. Hair Disorders Harper's Textbook of Pediatric Dermatology · 2019
    2. Minoxidil-Induced Hypertrichosis in a Child with Alopecia Areata Indian Dermatology Online Journal · 2017
    3. Minoxidil Induced Hypertrichosis in a 2-Year-Old Child F1000Research · 2013
    4. Hypertrichosis of Vellus Hairs in the Malar Region After Unilateral Treatment with Bimatoprost American Journal of Ophthalmology · 2004
    5. Hypertrichosis of Vellus Hairs in the Malar Region After Unilateral Treatment with Bimatoprost American Journal of Ophthalmology · 2004
    6. Diffuse Hypertrichosis During Treatment with 5% Topical Minoxidil British Journal of Dermatology · 1997
    7. Hypertrichosis Due to Minoxidil British Journal of Dermatology · 1979
    8. Minoxidil-Induced Hypertrichosis: Treatment with Calcium Thioglycolate Depilatory PubMed · 1977